知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

61 records (took 0.02 seconds)

    Medical system for a plurality of operators to perform an operation of one medical instrument in collaboration
    2.
    发明授权
    Medical system for a plurality of operators to perform an operation of one medical instrument in collaboration 有权
    用于多个操作者合作执行一个医疗器械的操作的医疗系统

    公开(公告)号：US08449455B2

    公开(公告)日：2013-05-28

    申请号：US12899697

    申请日：2010-10-07

    Applicant: Kazuki Honda ,  Wataru Matsuura ,  Yasuhito Kura ,  Yuji Sakamoto

    Inventor： Kazuki Honda ,  Wataru Matsuura ,  Yasuhito Kura ,  Yuji Sakamoto

    IPC: A61B1/00 ,  G05B23/02

    CPC classification number: A61B1/0052 ,  A61B1/00016 ,  A61B1/00039 ,  A61B1/00154 ,  A61B1/0016 ,  A61B18/1492 ,  A61B34/20 ,  A61B2090/064

    Abstract: A medical system includes: a first operation apparatus used when a first doctor operates a medical instrument; a second operation apparatus that outputs a control instruction signal for controlling a motion of the medical instrument, and is operated by a second doctor; at least one medical action information detection section that detects medical action information based on the motion of the medical instrument when the first doctor operates the medical instrument using the first operation apparatus; a storage apparatus that stores reference information set by the second doctor according to the first doctor for comparing with the medical action information detected by the medical action information detection section; a switching signal generation apparatus that is connected to the second operation apparatus, and switches an output destination of the control instruction signal based on the medical action information detected by the medical action information detection section and the reference information stored in the storage apparatus; and a medical instrument control apparatus that controls the medical instrument according to the control instruction signal of the second operation apparatus outputted from the switching signal generation apparatus.

    Abstract translation: 医疗系统包括：当第一医生操作医疗器械时使用的第一操作装置; 输出用于控制医疗器具的运动的控制指示信号并由第二医生操作的第二操作装置; 至少一个医疗动作信息检测部，其在所述第一医生使用所述第一操作装置操作所述医疗器械时，基于所述医疗器械的运动来检测医疗动作信息; 存储装置，存储由第一医生根据第一医生设定的参考信息，与医疗动作信息检测部检测出的医疗动作信息进行比较; 切换信号生成装置，其与第二运算装置连接，根据由医疗动作信息检测部检测出的医疗动作信息和存储在存储装置中的参考信息，切换控制指示信号的输出目的地; 以及医疗仪器控制装置，其根据从切换信号生成装置输出的第二运算装置的控制指示信号来控制医疗器械。

    THERAPEUTIC AGENT (Y-39983) FOR CORNEAL ENDOTHELIAL DYSFUNCTION
    3.
    发明申请
    THERAPEUTIC AGENT (Y-39983) FOR CORNEAL ENDOTHELIAL DYSFUNCTION 审中-公开
    治疗药物（Y-39983）用于角膜内膜功能障碍

    公开(公告)号：US20120288482A1

    公开(公告)日：2012-11-15

    申请号：US13519682

    申请日：2010-12-28

    Applicant: Hiroaki Takahashi ,  Yuji Sakamoto ,  Tetsuo Kida ,  Takeshi Tarui

    Inventor： Hiroaki Takahashi ,  Yuji Sakamoto ,  Tetsuo Kida ,  Takeshi Tarui

    IPC: A61K31/437 ,  A61K35/44 ,  A61P27/02

    CPC classification number: A61K31/437 ,  A61K9/0048 ,  A61K9/08 ,  C12N5/0621 ,  C12N2501/999

    Abstract: The present invention aims to provide a means for effectively and conveniently treating diseases wherein corneal endothelial cells poor in proliferative capacity in vivo are damaged. The present invention provides a therapeutic agent for corneal endothelial dysfunction containing (R)-(+)-N-(1H-pyrrolo [2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide or a pharmacologically acceptable salt thereof (compound (Ia)) as active ingredient, an agent for promoting adhesion of corneal endothelial cells, containing compound (Ia), a culture medium for corneal endothelial cells, containing the agent for promoting adhesion, an implant for corneal endothelial keratoplasty, containing corneal endothelial cells, scaffold and compound (Ia), and a production method of a corneal endothelial preparation, including a step of cultivating corneal endothelial cells using the culture medium.

    Abstract translation: 本发明旨在提供一种有效且方便地治疗疾病的手段，其中体内增殖能力差的角膜内皮细胞被破坏。 本发明提供了含有（R） - （+） - N-（1H-吡咯并[2,3-b]吡啶-4-基）-4-（1-氨基乙基）苯甲酰胺的角膜内皮功能障碍的治疗剂 -3983>或其药理学上可接受的盐（化合物（Ia））作为活性成分，用于促进角膜内皮细胞粘附的试剂，含有化合物（Ia），用于角膜内皮细胞的培养基，其含有促进粘附的试剂， 用于角膜内皮角膜移植术的植入物，其包含角膜内皮细胞，支架和化合物（Ia），以及角膜内皮制剂的制备方法，包括使用培养基培养角膜内皮细胞的步骤。

    Method and apparatus for cutting away excess synthetic resin from synthetic resin package of electronic component
    4.
    发明申请
    Method and apparatus for cutting away excess synthetic resin from synthetic resin package of electronic component 审中-公开
    从电子部件合成树脂封装中切掉多余的合成树脂的方法和装置

    公开(公告)号：US20060014324A1

    公开(公告)日：2006-01-19

    申请号：US11216257

    申请日：2005-08-31

    Applicant: Yuji Sakamoto

    Inventor： Yuji Sakamoto

    IPC: H01L21/44

    CPC classification number: B29C37/02 ,  B29C2793/009 ,  Y10T156/108 ,  Y10T156/12

    Abstract: A method is provided for cutting excess synthetic resin 7, which projects from a resin package 6 of an electronic component, at the root connected to the package, the excess synthetic resin being produced in molding the resin package. The excess synthetic resin 7 is cut by laying a thin plate 11 on an obverse surface of the resin package 7 while allowing the excess synthetic resin to penetrate therethrough, followed by moving a cutter 13 along and relative to the obverse surface of the thin plate 13. Alternatively, the cutting is performed by laying a cutter plate and a support plate on the obverse surface of the package 7 while allowing the excess synthetic resin to penetrate through the both plates followed by performing relative movement of the cutter plate.

    Abstract translation: 提供一种切割多余的合成树脂7的方法，该多余的合成树脂7从与电子部件的树脂封装6突出的根部连接到封装，多余的合成树脂是在树脂封装成型时制造的。 通过在树脂封装7的正面上放置薄板11，同时使多余的合成树脂穿过其中，然后沿着薄板13的正面移动切割器13，切割多余的合成树脂7 。 或者，通过将切割板和支撑板铺设在包装7的正面上来进行切割，同时允许多余的合成树脂穿过两个板，随后执行切割板的相对运动。

    Treatment system for living tissues
    5.
    发明申请
    Treatment system for living tissues 审中-公开
    活体组织治疗系统

    公开(公告)号：US20050261710A1

    公开(公告)日：2005-11-24

    申请号：US11133004

    申请日：2005-05-19

    Applicant: Yuji Sakamoto ,  Satoshi Miyamoto ,  Norio Onishi

    Inventor： Yuji Sakamoto ,  Satoshi Miyamoto ,  Norio Onishi

    IPC: A61B17/04 ,  A61B17/06 ,  A61B17/12

    CPC classification number: A61B17/0487 ,  A61B17/0401 ,  A61B17/0467 ,  A61B17/0469 ,  A61B17/0482 ,  A61B17/12013 ,  A61B2017/0404 ,  A61B2017/0417 ,  A61B2017/0458 ,  A61B2017/0464 ,  A61B2017/049 ,  A61B2017/0496 ,  A61B2017/06052

    Abstract: A medical treatment device includes a suturing-ligating member, a stopper, a fixing member and a suturing-ligation releasing member. The suturing-ligating member has a distal end portion, that carries out one of suturing and ligation of biological tissue by puncturing. The stopper is provided to be movable forward or backward on the suturing-ligating member, and stoppable by friction on the suturing-ligating member to maintain the biological tissue in a sutured or ligated state by the suturing-ligating member. The fixing member is provided on the distal end side of the suturing-ligating member to fix the distal end side of the suturing-ligating member to the biological tissue. The releasing member is provided on the distal end side of the suturing-ligating member to release the ligation state maintained by frictional stopping between the suturing-ligating member and the stopper by moving the suturing-ligating member to the distal end portion side with respect to the stopper.

    Abstract translation: 医疗处理装置包括缝合结扎构件，止动件，固定构件和缝合结扎释放构件。 缝合连接部件具有远端部，通过穿刺进行生物组织的缝合和连接之一。 该止动器设置成能够在缝合结扎构件上向前或向后移动，并且可以通过缝合结扎构件上的摩擦而停止，以通过缝合结扎构件将生物组织维持在缝合或结扎状态。 固定构件设置在缝合结合构件的远端侧，以将缝合结扎构件的远端侧固定到生物体组织。 释放构件设置在缝合结扎构件的远端侧，以通过相对于缝合结合构件的远端部侧移动缝合结扎构件来释放通过缝合结扎构件和止动件之间的摩擦阻止而保持的结扎状态 塞子。

    Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytography
    6.
    发明授权
    Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytography 失效
    用于预防和治疗眼底组织细胞病变相关疾病的药物组合物

    公开(公告)号：US06423691B1

    公开(公告)日：2002-07-23

    申请号：US09623393

    申请日：2000-09-05

    Applicant: Mitsuyoshi Azuma ,  Yukuo Yoshida ,  Yuji Sakamoto ,  Jun Inoue

    Inventor： Mitsuyoshi Azuma ,  Yukuo Yoshida ,  Yuji Sakamoto ,  Jun Inoue

    IPC: A61K3800

    CPC classification number: A61K38/00 ,  A61K31/18

    Abstract: A pharmaceutical composition for the prophylaxis and therapy of a disease arising from ocular fundus tissue cytopathy such as retinochoroidal disease, glaucoma, and posterior complication arising form photocoagulation, which contains, as an active ingredient, a compound of formula (I) wherein R1 represents an alkyl group having 1 to 4 carbon atoms or an aryl group having 6 to 10 carbon atoms which is optionally substituted; R2 and R3 may be the same or different and each represents hydrogen or an alkyl group having 1 to 4 carbon atoms or R2 and R3 may jointly form a ring having 3 to 7 carbon atoms; and R4 represents a lower alkyl group which substituted by aryl, cycloalkyl, or aromatic heterocyclic residue, or a pharmaceutically acceptable salt thereof.

    Abstract translation: 一种用于预防和治疗由眼底组织细胞病变（例如视网膜色素性疾病，青光眼和由光凝产生的后期并发症）引起的疾病的药物组合物，其包含作为活性成分的式（I）化合物，其中R 1表示 具有1至4个碳原子的烷基或任选被取代的具有6至10个碳原子的芳基; R2和R3可以相同或不同，各自表示氢或具有1-4个碳原子的烷基，或者R2和R3可以共同形成具有3至7个碳原子的环; R 4表示被芳基，环烷基或芳香杂环残基取代的低级烷基或其药学上可接受的盐。

Patent Agency Ranking